LOX-1 as a natural IFN-α-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells

Blood

Volumn 115, Issue 8, 2010, Pages 1554-1563

  Parlato, Stefania ^a   Romagnoli, Giulia ^a   Spadaro, Francesca ^a   Canini, Irene ^a   Sirabella, Paolo ^a   Borghi, Paola ^a   Ramoni, Carlo ^a   Filesi, Ilaria ^b   Biocca, Silvia ^b   Gabriele, Lucia ^a   Belardelli, Filippo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; IMMUNOLOGIC FACTOR; OLR1 PROTEIN, HUMAN;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

ANTIGEN PRESENTATION; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; SCAVENGER RECEPTORS, CLASS E; SIGNAL TRANSDUCTION;

EID: 77949881623     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-234468     Document Type: Article

References (49)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419-426.
2. Liu G, Wu C, Wu Y, Zhao Y. Phagocytosis of apoptotic cells and immune regulation. Scand J Immunol. 2006;64(1):1-9. (Pubitemid 44195097)
3. Jeannin P, Jaillon S, Delneste Y. Pattern recognition receptors in the immune response against dying cells. Curr Opin Immunol. 2008;20(5):530-537.
4. Dalgaard J, Beckstrøm KJ, Jahnsen FL, Brinchmann JE. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets. J Leukoc Biol. 2005;77(5):689-698. (Pubitemid 40628749)
5. Obeid M, Panaretakis T, Tesniere A, et al. Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic. Cancer Res. 2007;67(17):7941-7944.
6. Rawson PM, Molette C, Videtta M, et al. Crosspresentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat Med. 2007;13(12): 1431-1439. (Pubitemid 350224247)
7. Winau F, Weber S, Sad S, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity. 2006;24(1):105-117. (Pubitemid 43077204)
8. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol. 2007;7(12):964-974. (Pubitemid 350166061)
9. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 2008; 15(2):243-250.
10. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386(6620):73-77. (Pubitemid 27130922)
11. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J. 2008;409(2):349-355.
12. Honjo M, Nakamura K, Yamashiro K, et al. Lectinlike oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci U S A. 2003;100(3): 1274-1279. (Pubitemid 36183992)
13. Calderwood SK, Mambula SS, Gray PJ Jr, Theriault JR. Extracellular heat shock proteins in cell signaling. FEBS Lett. 2007;581(19):3689-3694. (Pubitemid 47081004)
14. Delneste Y, Magistrelli G, Gauchat J, et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity. 2002; 17(3):353-362. (Pubitemid 35279555)
15. Nishikawa M, Takemoto S, Takakura Y. Heat shock protein derivatives for delivery of antigens to antigen presenting cells. Int J Pharm. 354(1-2): 23-27, 2008.
16. Santini SM, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocytederived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med. 2000;191(10):1777-1788. (Pubitemid 30331574)
17. Gabriele L, Borghi P, Rozera C, et al. IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment. Blood. 2004; 103(3):980-987. (Pubitemid 38129560)
18. + T-cell help. Eur J Immunol. 2006;36(8): 2046-2060.
19. Gigante M, Mandic M, Wesa AK, et al. Interferonalpha (IFN-alpha)- conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients. J Immunother. 2008;31(3):254-262.
20. Korthals M, Safaian N, Kronenwett R, et al. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J Transl Med. 2007;5:46. (Pubitemid 350066534)
21. Santodonato L, D'Agostino G, Nisini R, et al. Monocyte-derived dendritic cells generated after a short-term culture with IFN-α and granulocytemacrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response. J Immunol. 2003;170(10):5195-5202. (Pubitemid 36554752)
22. + T-cell responses against human tumor antigens. J Immunol. 2004;172(9):5363-5370.
23. Belardelli F, Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 2002;23(4):201-208. (Pubitemid 34260936)
24. Tough DF. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk Lymphoma. 2004;45(2):257-264.
25. Irizarry RA, Gautier L, Cope L. An R package for analyses of Affymetrix oligonucleotide arrays. In: Parmigiani G, Garret ES, Zeger S, eds. The Analysis of Gene Expression Data: Methods and Software. New York: Springer; 2003.
26. Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comp Graph Stat. 1996; 5(3):299-314.
27. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116-5121. (Pubitemid 32397092)
28. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003; 4(10):R70.
29. Biocca S, Filesi I, Mango R, et al. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. J Mol Cell Cardiol. 2008;44(3):561-570.
30. Liang M, Zhang P, Fu J. Up-regulation of LOX-1 expression by TNF-alpha promotes transendothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett. 2007;258(1):31-37. (Pubitemid 47600486)
31. Kepp O, Tesniere A, Schlemmer F, et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis. 2009;14(4):364-375.
32. Schettini J, Mukherjee P. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin Dev Immunol. 2008; doi:10.1155/2008/106321.
33. Thurnher M, Zelle-Rieser C, Ramoner R, Bartsch G, Höltl L. The disabled dendritic cell. FASEB J. 2001;15(6):1054-1061.
34. Kanazawa N. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. J Dermatol Sci. 2007;45(2):77-86. (Pubitemid 46108481)
35. Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008;19(1):41-52.
36. Castellino F, Boucher PE, Eichelberg K, et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med. 2000;191(11):1957-1964. (Pubitemid 30390357)
37. Kurotaki T, Tamura Y, Ueda G, et al. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol. 2007;179(3):1803-1813.
38. + T-cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors. Cancer Sci. 2008;99(5):1008-1015.
39. + cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes. Autoimmunity. 2008;41(7):501-511.
40. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315(5808):107-111. (Pubitemid 46196991)
41. Burgdorf S, Kautz A, Böhnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T-cell activation. Science. 2007;316(5824):612-616. (Pubitemid 46683149)
42. Jensen PE. Recent advances in antigen processing and presentation. Nat Immunol. 2007;8(10): 1041-1048. (Pubitemid 47423752)
43. Zhou D, Li P, Lin Y, et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity. 2005;22(5):571-581. (Pubitemid 40719193)
44. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392(6671): 86-89. (Pubitemid 28150594)
45. Wang QJ, Hanada K, Yang JC. Characterization of a novel nonclassical T-cell clone with broad reactivity against human renal cell carcinomas. J Immunol. 2008;181(6):3769-3776.
46. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 2001;294(5546):1540-1543. (Pubitemid 33063928)
47. Borg FA, Isenberg DA. Syndromes and complications of interferon therapy. Curr Opin Rheumatol. 2007;19(1):61-66.
48. Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med. 2006; 354(7):709-718. (Pubitemid 43247141)
49. Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008;19(1):41-52.